IBDEI0NA ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10865,1,4,0)
 ;;=4^L93.0
 ;;^UTILITY(U,$J,358.3,10865,2)
 ;;=^5009467
 ;;^UTILITY(U,$J,358.3,10866,0)
 ;;=L93.1^^47^522^56
 ;;^UTILITY(U,$J,358.3,10866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10866,1,3,0)
 ;;=3^Lupus Erythematosus,Subacute Cutaneous
 ;;^UTILITY(U,$J,358.3,10866,1,4,0)
 ;;=4^L93.1
 ;;^UTILITY(U,$J,358.3,10866,2)
 ;;=^5009468
 ;;^UTILITY(U,$J,358.3,10867,0)
 ;;=L93.2^^47^522^55
 ;;^UTILITY(U,$J,358.3,10867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10867,1,3,0)
 ;;=3^Lupus Erythematosus,Other
 ;;^UTILITY(U,$J,358.3,10867,1,4,0)
 ;;=4^L93.2
 ;;^UTILITY(U,$J,358.3,10867,2)
 ;;=^5009469
 ;;^UTILITY(U,$J,358.3,10868,0)
 ;;=L04.9^^47^522^60
 ;;^UTILITY(U,$J,358.3,10868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10868,1,3,0)
 ;;=3^Lymphadenitis,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,10868,1,4,0)
 ;;=4^L04.9
 ;;^UTILITY(U,$J,358.3,10868,2)
 ;;=^5009074
 ;;^UTILITY(U,$J,358.3,10869,0)
 ;;=R59.1^^47^522^57
 ;;^UTILITY(U,$J,358.3,10869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10869,1,3,0)
 ;;=3^Lymph Nodes,Enlarged,Generalized
 ;;^UTILITY(U,$J,358.3,10869,1,4,0)
 ;;=4^R59.1
 ;;^UTILITY(U,$J,358.3,10869,2)
 ;;=^5019530
 ;;^UTILITY(U,$J,358.3,10870,0)
 ;;=R59.0^^47^522^58
 ;;^UTILITY(U,$J,358.3,10870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10870,1,3,0)
 ;;=3^Lymph Nodes,Enlarged,Localized
 ;;^UTILITY(U,$J,358.3,10870,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,10870,2)
 ;;=^5019529
 ;;^UTILITY(U,$J,358.3,10871,0)
 ;;=R59.9^^47^522^59
 ;;^UTILITY(U,$J,358.3,10871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10871,1,3,0)
 ;;=3^Lymph Nodes,Enlarged,Unspec
 ;;^UTILITY(U,$J,358.3,10871,1,4,0)
 ;;=4^R59.9
 ;;^UTILITY(U,$J,358.3,10871,2)
 ;;=^5019531
 ;;^UTILITY(U,$J,358.3,10872,0)
 ;;=L60.9^^47^522^61
 ;;^UTILITY(U,$J,358.3,10872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10872,1,3,0)
 ;;=3^Nail Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,10872,1,4,0)
 ;;=4^L60.9
 ;;^UTILITY(U,$J,358.3,10872,2)
 ;;=^5009240
 ;;^UTILITY(U,$J,358.3,10873,0)
 ;;=L60.3^^47^522^62
 ;;^UTILITY(U,$J,358.3,10873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10873,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,10873,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,10873,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,10874,0)
 ;;=L60.0^^47^522^63
 ;;^UTILITY(U,$J,358.3,10874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10874,1,3,0)
 ;;=3^Nail,Ingrowing
 ;;^UTILITY(U,$J,358.3,10874,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,10874,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,10875,0)
 ;;=L60.2^^47^522^70
 ;;^UTILITY(U,$J,358.3,10875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10875,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,10875,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,10875,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,10876,0)
 ;;=L97.109^^47^522^69
 ;;^UTILITY(U,$J,358.3,10876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10876,1,3,0)
 ;;=3^Nonpressure Chr Ulcer of Thigh
 ;;^UTILITY(U,$J,358.3,10876,1,4,0)
 ;;=4^L97.109
 ;;^UTILITY(U,$J,358.3,10876,2)
 ;;=^5009484
 ;;^UTILITY(U,$J,358.3,10877,0)
 ;;=L97.209^^47^522^65
 ;;^UTILITY(U,$J,358.3,10877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10877,1,3,0)
 ;;=3^Nonpressure Chr Ulcer of Calf
 ;;^UTILITY(U,$J,358.3,10877,1,4,0)
 ;;=4^L97.209
 ;;^UTILITY(U,$J,358.3,10877,2)
 ;;=^5009499
 ;;^UTILITY(U,$J,358.3,10878,0)
 ;;=L97.309^^47^522^64
 ;;^UTILITY(U,$J,358.3,10878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10878,1,3,0)
 ;;=3^Nonpressure Chr Ulcer of Ankle
 ;;^UTILITY(U,$J,358.3,10878,1,4,0)
 ;;=4^L97.309
 ;;^UTILITY(U,$J,358.3,10878,2)
 ;;=^5009514
 ;;^UTILITY(U,$J,358.3,10879,0)
 ;;=L97.409^^47^522^67
